A 58-year-old woman has paroxysmal non-valvular atrial fibrillation. She has no hypertension, diabetes, heart failure, vascular disease, or prior stroke/TIA and is a non-smoker. According to the CCS atrial fibrillation guideline and CHADS-65 approach, what is the most appropriate antithrombotic strategy?